Chengdu Haibowei Pharmaceutical Co., Ltd.
海博为药业
Chengdu Haibowei Pharmaceutical Co., Ltd.
Biotech/Healthcare
Haibowei Pharmaceutical is an R&D-driven drug developer and manufacturer. It is building internationally competitive platforms for innovative small-molecule drugs, high-end active pharmaceutical ingredients, and generic drugs with high technical barriers.
Latest round: Series B Extension (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-09-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.